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AbstrAct
Human epidemiological and experimental animal studies show that suboptimal environments in fetal and neonatal life exerts a 
profound influence on physiological function and risk of disease in adult life. The molecular, cellular, metabolic, endocrine and physi-
ological adaptations to intrauterine nutritional conditions result in permanent alterations of cellular proliferation and differentiation of 
tissues and organ systems, which in turn can manifest by pathological consequences or increased vulnerability to chronic diseases in 
adulthood. Intrauterine growth restriction (IUGR) due to intrauterine development derangements is considered the important factor 
in development of such diseases as essential hypertension, diabetes mellitus, ischemic diseases of the heart, osteoporosis, respiratory, 
neuropsychiatric and immune system diseases.
An early life exposures to dietary and environmental exposures can have a important effect on epigenetic code, resulting in diseases 
developed later in life. The concept of the "developmental programming" and Developmental Origins of Adult Diseases (DOHaD) has 
become well accepted because of the compelling animal studies that have precisely defined the outcomes of specific exposures. 
The environmental pollullutants and other chemical toxicants may influence crucial cellular functions during critical periods of fetal 
development and permanently alter the structure or function of specific organ systems. Developmental epigenetics is believed to 
establish "adaptive" phenotypes to meet the demands of the later-life environment. Resulting phenotypes that match predicted later-
life demands will promote health, while a high degree of mismatch will impede adaptability to later-life challenges and elevate disease 
risk. The rapid introduction of synthetic chemicals, environmental pollutants and medical interventions, may result in conflict with the 
programmed adaptive changes made during early development, and explain the alarming increases in some diseases.
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Introduction
Chronic  diseases  (CDs)  are  the  greatest  public  health 
problem,  either  in  terms  of  direct  cost  to  society  and 
government,  or  in  terms  of  disability  lasting  for  years. 
They  include  cardiovascular  diseases,  diabetes,  cancer, 
osteoporosis, obesity, etc. The burden of chronic diseases 
is rapidly increasing worldwide. It has been calculated that 
in 2001 chronic diseases contributed approximately by 60% 
to the 56.5 million total reported deaths in the world and 
approximately 46% to the global burden of disease. The pro-
portion of the burden of CDs is expected to increase to 57% 
by 2020. Almost half of the total chronic disease deaths are 
attributable to cardiovascular diseases; obesity and diabetes 
are also showing worrying trends, not only because they 
already affect a large proportion of the population but also 
because they have started to appear earlier in life. The origin 
of CDs is considered to be related to four relevant factors 
in fetal life are: (1) intrauterine growth retardation (IUGR); 
(2) premature delivery of a normal growth for gestational 
age fetus; (3) overnutrition in utero and (4) intergenerational 
factors. There is considerable evidence that IUGR is associ-
ated with an increased risk of coronary heart disease, stroke, 
diabetes  and  raised  blood  pressure  (WHO/FAO  Expert 
Consultation)
Fetal Environment
The  fetal  environment  is  determined  by  the  maternal 
environment and by maternal and placental physiology. 
Growth (an increase in the number and size of cells or 
in the mass of tissues) and development (changes in the 
structure and function of cells or tissues) of the fetus are 
complex biological events influenced by genetic, epigenetic, 
maternal  maturity,  as  well  as  environmental  and  other 
factors (Wu et al., 2006). These factors affect the size and 
functional capacity of the placenta, uteroplacental transfer 
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of nutrients and oxygen from mother to fetus, conceptus 
nutrient availability, fetal endocrine milieu, and metabolic 
pathways. Optimal fetal growth is essential for perinatal 
survival and has long-term consequences extending into 
adulthood. In conditions of severe intrauterine deprivation, 
there is a capacity to lose structural units such as nephrons, 
cardiomyocytes, or pancreatic beta-cells within developing 
organ systems. It is not clear if such responses are either 
adaptive or predictive, although it is obvious that they will 
result in the programming of a reduced functional capacity 
for life. Programming is defined as a permanent or long-
term change in the physiology, morphology, or metabolism 
of a fetus in response to a specific insult or stimulus at a 
critical period in development. Any programming of an 
organism or tissue may be regarded as the consequence of 
an adaptation that is necessary to survive an insult (Barker, 
1998). Developmental epigenetics is believed to establish 
adaptive phenotypes to meet the demands of the later-life 
environment. Resulting phenotypes that match predicted 
later-life demands will promote health, while a high degree 
of mismatch will impede adaptability to later-life challenges 
and elevate disease risk (Gluckman and Hanson, 2007).
Epigenetic Reprogramming
Epigenetics is defined as heritable changes in gene expres-
sion that do not alter DNA sequence but are mitotically and 
transgenerationally inheritable. Epigenetic reprogramming 
is the process by which an organ genotype interacts with the 
environment to produce its phenotype and provides a frame-
work for explaining individual variations and the uniqueness 
of cells, tissue, or organs despite identical genetic informa-
tion. The main epigenetic mediators are histon modification 
DNA methylation, and non-coding RNAs. They regulate 
crucial cellular functions such as genome stability, gene 
imprinting, and reprogramming of non-imprinting genes 
(Tang and Ho, 2007) 
Toxicants During Development
The periods of embryonic, fetal and infant development 
are remarkably susceptible to environmental hazards. The 
environmental pollutants and other chemical toxicants may 
influence crucial cellular functions during critical periods 
of fetal development and permanently alter the structure 
or function of specific organ systems. Toxic exposures to 
chemical pollutants during these windows of increased sus-
ceptibility can cause developmental changes, postnatal dis-
ease and disability in infants, children and across the entire 
span of human life. However, even subtle changes caused by 
chemical exposures during early development may lead to 
important functional deficits and increased risks of disease 
later in life. The timing of exposure during early develop-
ment is a crucial factor to be considered in toxicological 
assessments (Grandjean et al., 2008). Emerging evidence 
shows that redox-sensitive signal transduction pathways are 
critical for developmental processes, including proliferation, 
differentiation, and apoptosis. As a consequence, teratogens 
that induce oxidative stress may induce teratogenesis via the 
misregulation of these pathways. Oxidizing and reducing 
equivalent imbalance in turn leads to macromolecule dam-
age, namely protein modification, lipid peroxidation, and 
DNA oxidation, and if unchecked, oxidative damage can lead 
to cell death. However, oxidative stress as a mechanism does 
not satisfactorily explain how it might serve as a mechanism 
of teratogenesis (Jason and Hansen, 2006).
Disturbances  during  the  developmental  period  may 
result in transient or irreversible long-term effects. Birth 
defects associated with the common air pollutants may 
potentially result in increased vulnerability of the respiratory 
and cardiovascular systems during infancy and childhood. 
Intrauterine growth retardation and low birth weight have 
been linked to alterations of respiratory function at all stages 
of postnatal life and intrauterine growth retardation may 
lead to increased susceptibility to air pollution exposure and 
other environmental factors (Wang and Pinkerton 2007). 
Figure 1. Proposed pattern of epigenetic programming of chronic diseases.
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Toxicity Assessment
A major problem in assessing the contribution of the envi-
ronment to human health and diseases is the small number 
of toxicity data in relation with the high-production volume 
chemicals introduced into the environment. The toxicity 
studies that have been performed are, in most cases, less 
than satisfactory for assessing the risk to human health. The 
existing test systems are too costly and time-consuming to 
evaluate more than only a small fraction of the chemicals 
which would need toxicity assessment. Even worse it is with 
very persistent and bioaccumulative substances presenting 
serious concerns even though there may not be evidence of 
toxicity. Accumulative substances may cause subtle long-
term effects which may become evident in the future. 
Concluding Remarks
Finally,  good  biomarkers  of  early  molecular  alterations 
that lead to toxicity and chronic disease, resulting from 
environmental exposures, do not exist. Only early detection 
of interactions involving genes, gene-products and environ-
mental factors could lead to the development of effective 
prevention strategies and elucidation of mechanisms of 
pathogenesis (Olden 2004).
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